452
Views
62
CrossRef citations to date
0
Altmetric
Original Article

Rac Regulates Vascular Endothelial Growth Factor Stimulated Motility

, , , &
Pages 1-13 | Received 10 Feb 2000, Accepted 22 Apr 2000, Published online: 11 Jul 2009

References

  • Abedi H., Zachary I. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol. Chem. 1997; 272: 15442–15451
  • Altun-Gultekin Z. F., Wagner J. A. Src, ras, and rac mediate the migratory response elicited by NGF and PMA in PC 12 cells. J. Neurosci. Res. 1996; 44: 308–327
  • Anand-Apte B., Zetter B. R., Viswanathan A., Qiu R. G., Chen J., Ruggieri R., Symons M. Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by the Rac and extracellular signal-regulated kinase pathways. J. Biol. Chem. 1997a; 272: 30688–30692
  • Anand-Apte B., Zetter B. R. Signaling mechanisms in growth factor-stimulated cell motility. Stem Cell. 1997b; 15: 259–267
  • Aspenstrom P. Effectors for the Rho GTPases. Curr. Opin. Cell Biol. 1999; 11: 95–102
  • Ausprunk D. H., Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Micro vase Res. 1977; 14: 53–65
  • Beauvais-Journeau A., Thiery J. P. Multiple roles for integrins during development. Biology of the Cell 1997; 89: 5–11
  • Braga V. M., Machesky L. M., Hall A., Hotchin N. A. The small GTPases rho and rac are required for the establishment of cadherin-dependent cell-cell contacts. J. Cell Biol. 1997; 137: 1421–1431
  • Breier G. The role of vascular endothelial growth factor in blood vessel formation. Trends in Cell Biology 1996; 6: 454–456
  • Brogi E., Wu T., Namiki A., Isner J. M. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscular cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994; 90: 649–652
  • Brown L. F., Papadopoulos-Sergiou A., Berse B., Manseau E. J., Tognazzi K., Perruzzi C. A., Dvorak H. F., Senger D. R. Osteopontin expression and distribution in human carcinoma. Am J. Pathol. 1994; 145: 610–623
  • Chen Z., Fisher R. J., Riggs C. W., Rhim J. S., Lautenberger J.A. Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. Cancer Res. 1997; 57: 2013–2019
  • Chu C. R., Convery F. R., Akeson W. H., Meyers M., Amiel D. Articular cartilage transplantation. Clin. Orthop. Relat. Res. 1998; 360: 159–168
  • Connolly J. O., Soga N., Guo X. L., Alvarez U., Hruska K. A. Rac is essential in the transformation of endothelial cells by polyoma middle T. Cell adhesion and communication 2000; 7: 409–422
  • Cramer L. P., Siebert M., Mitchison T. J. Identification of novel graded polarity actin filament bundles in locomoting heart fibroblasts: implications for the generation of motil force. J. Cell Biol. 1997; 136: 1287–1305
  • Denhardt D. T., Guo X. Osteopontin: a protein with diverse functions. FASEB J. 1993; 7: 1475–1482
  • Esser S., Lampugnani M. G., Corada M., Dejana E., Risau W. Vascular endothelial growth factor induces VE-cadherin thyrosine phosphorylation in endothelial cells. J. Cell Sci. 1998; 111: 1853–1865
  • Evan G. I., Lewis G. K., Ramsay G., Bishop J. M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene. Mol. Cell Biol. 1985; 5: 3610–3616
  • Ferrara N. Vascular endothelial growth factor. Trends Cardiovasc Med. 1993; 3: 244–250
  • Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. PNAS 1992; 89: 5547–5551
  • Guo D., Jia Q., Song H. Y., Warren R. S., Donner D. B. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction thats contain SH2domains. J. Biol. Chem. 1995; 270: 6729–6733
  • Hall A. Rho GTPases and the actin cytoskeleton. Science 1998; 279: 509–514
  • Hordijk P. L., ten Klooster J. P., van der Kammen R. A., Michiels F., Oomen L. C., Vollard J. G. Inhibition of invasion of epithelial cells by Tiaml-rac signaling. Science 1997; 278: 1464–1466
  • Howe A., Aplin A. E., Alahari S. K., Juliano R. L. Integrin signaling and cell growth control. Current Opinion in Cell Biology 1998; 10: 220–231
  • Keely P. J., Westwick J. K., Whitehead IP., Der C. J., Parise L. V. Cdc42 and Rac 1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature 1997; 390: 632–636
  • Kevil C. G., Payne D. K., Mire E., Alexander J. S. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J. Biol. Chem. 1998; 273: 15099–15103
  • Kumar C. C. Signaling by integrin receptors. Oncogene 1998; 17: 1365–1373
  • Lauffenburger A. D. Cell migration: a physically integrated molecular process. Cell 1996; 84: 359–369
  • Leavesley D. I., Schwartz M. A., Rosenfeld M., Cheresh D. A. Integrin β1- and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J. Cell Biol. 1993; 121: 163–170
  • Liaw L., Almeida M., Hart C. E., Schwartz S. M., Giachelli C. M. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circulation Research 1994; 74: 214–224
  • Mackay D. J., Hall A. Rho GTPases. J. Biol. Chem. 1998; 273: 20685–20688
  • Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N. P., Risau W., Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72: 835–846
  • Muhlner U., Mohle-Steinlein U., Wizigmann-Voos S., Christofori G., Risau W., Wagner E. F. Formation of transformed endothelial cells in the absence of VEGFR-2/Flk-l by polyoma middle T oncogene. Oncogene 1999; 18: 4200–4210
  • Mustonen T., Alitalo K. Endothelial receptor tyrosine kinases involved in angiogenesis. J. Cell. Biol. 1995; 129: 895–898
  • Namiki A., Brogi E., Kearney M., Kim E. A., Wu T., Couffinhal T., Varticovski L., Isner J. M. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J. Biol. Chem. 1995; 270: 31189–31195
  • Nobes C. D., Hall A. Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995; 81: 53–62
  • Oldberg A., Franzen A., Heinegard D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell binding sequence. PNAS 1986; 83: 8819–8823
  • Owens E. M., Solursh M. Cell-cell interaction by mouse limb cells duringin vitrochondrogenesis: analysis of the brachypod mutation. Developmental Biology 1982; 91: 376–388
  • Parenti A., Donnini S., Morbidelli L., Granger H. J., Ziche M. The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor. British Journal of Pharmacology 1996; 119: 619–621
  • Qiu R.-G., Chen J., Kirn D., McCormick F., Symons M. An essential role for Rac in Ras transformation. Nature 1995; 374: 457–459
  • Raptis L., Marcellus R., Corbley M. J., Krook A., Whitfield J., Anderson S. K., Haliotis T. Cellular ras gene activity is required for full neoplastic transformation by polyomavirus. J. Virol. 1991; 65: 5203–5210
  • Ridley A. J., Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992; 70: 389–399
  • Roeckl W., Hecht D., Sztajer H., Waltenberger J., Yayon A., Weich H. A. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp. Cell Res. 1998; 241: 161–170
  • Romer L. H., McLean N., Turner C. E., Burridge K. Tyrosine kinase activity, cytoskeletal organization, and motility in human vascular endothelial cells. Mol. Biol. Cell. 1994; 5: 349–361
  • Rousseau S., Houle F., Landry J., Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 1997; 15: 2169–2177
  • Senger D. R., Ledbetter S. R., Claffey K. P., Papadopoulos-Sergiou A., Perruzzi C. A., Detmar M. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the αv β3integrin, osteopontin, and thrombin. Am. J. Pathol. 1996a; 149: 293–305
  • Senger D. R., Peruzzi C. A. Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin. Biochimica el Biophysica Acta 1996b; 1314: 13–24
  • Seymour L. W., Shoaibi M. A., Martin A., Ahmed A., Elvin P., Kerr D. J., Wakelam M. J. Vascular endothelial growth factor stimulates protein kinase C-dependent phospholipase D activity in endothelial cells. Lab. Invest. 1996; 75: 427–437
  • Shibuya M. Role of VEGF-Flt receptor system in normal and tumor angiogenesis. Cancer Res. 1995; 67: 281–316
  • Shockett P., Difilippantonio M., Hellman N., Schatz D. G. A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. PNAS 1995; 92: 6522–6526
  • Soker S., Fidder H., Neufeld G., Klagsbrun M. Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J. Biol. Chem. 1996; 271: 5761–5767
  • Stasia M. J., Jouan A., Bourmeyster N., Bouquet P., Vignais P. V. ADP-ribosylation of a small size GTP-binding protein in bovine neutrophils by the C3 exoenzyme of Clostridium botulinum and effect of the cell motility. Biochemical and Biophysical Research Communications 1991; 180: 615–622
  • Takaishi K., Sasaki T., Kato M., Yamochi W., Uroda S., Nakamura T., Takeichi M., Takai Y. Involvement of Rho p21 small-binding protein and its regulator in the HGF-induced cell motility. Oncogene 1994; 9: 273–279
  • Wagner E. F., Risau W. Oncogenes in the study of endothelial cell growth and differentiation. Semin. Cancer Biol. 1987; 5: 137–145
  • Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., Heldin C. H. Different signal transduction properties of KDR and Fltl, two receptors for vascular endothelial growth factor. J. Biol. Chem. 1994; 269: 26988–26995
  • Weber G. F., Ashkar S., Glimcher M. J., Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996; 271: 509–512
  • White F. C., Carrdl S. M., Kamps M. K. VEGF mRNA is reversibly stabilized by hypoxia and persistently stabilized in VEGF overexpressing human tumor cell lines. Growth Factors 1995; 12: 289–301
  • Williams R. L., Courtneidge S. A., Wagner E. F. Embryonic lethalities and endothelial tumours in chimeric mice expressing polyoma middle T oncogene. Cell 1988; 52: 121–131
  • Wojciak-Stothard B., Entwistle A., Garg R., Ridley A. J. Regulation of TNF-α-induced reorganization of the actin cytoskeleton and cell-cell junctions by rho, rac, and cdc42 in human endothelial cells. J. Cellular Physiol 1998; 176: 150–165
  • Yoshida A., Anand-Apte B., Zetter B. R. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors 1996; 13: 57–64

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.